ZachXBT says Figure RWA metrics cannot be fully verified on-chain, DefiLlama founder responds
Foresight News reported that on-chain detective ZachXBT tweeted about the incident where blockchain lending platform Figure publicly pressured DeFiLlama, stating that Figure attempted to exert public pressure on honest participants like DeFiLlama using its RWA metrics, which cannot be fully verified on-chain.
Subsequently, DefiLlama founder 0xngmi tweeted that DefiLlama discovered a significant discrepancy between Figure's on-chain assets and trading volume: BTC and ETH reserves are minimal, its own stablecoin supply is limited, most loans are still processed in fiat currency, and there is almost no on-chain transaction activity. They suspect that most of Figure's TVL may simply be a mirror of its internal database rather than actual tradable assets.
As part of due diligence, DefiLlama has discussed Figure's TVL data (claimed to be $12 billions) with the Figure team in a Telegram group chat, raising multiple questions regarding their systems and issuance. However, a person familiar with the entire process spread rumors on X (formerly Twitter) that DefiLlama refused to list Figure due to its follower count on X, and some even implied that DefiLlama charges listing fees, which is completely untrue. In fact, DefiLlama has never refused any project due to follower numbers, nor has it charged any fees, and continues to adhere to strict due diligence to ensure the authenticity and reliability of the data.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
No scientific evidence but viral on social media: “Bodybuilding miracle drug” peptide products deregulation file sent to the White House for review, Hims&Hers (HIMS.US) surged 6% in one day.
The temporary admission policy for peptides has been submitted to the White House for review, and compounding pharmacies are expected to receive approval to produce BPC-157 and other substances; HIMS closed up 6% on Thursday.
AiCoin丨10.16 Snapshot: PPI Exceeds Expectations, Russia Bans P2P, US Stock ETF Net Outflow
Yen barely gains on a BoJ push for hikes and a Tokyo stock rout

IEA agrees to release of outstanding 100 million barrels of oil

